SDIX, LLC is a company that specializes in the development and production of high-quality antibodies and related products for the in vitro diagnostics (IVD), anatomic pathology, biotechnology, and pharmaceutical markets. The company offers a range of products, including monoclonal and polyclonal antibodies, calibrators, and controls, as well as contract manufacturing services for large-scale antibody production. SDIX's services include antibody development, production, and purification, with a focus on providing high-performance diagnostic and commercialization solutions to its customers. The company operates state-of-the-art, ISO 13485:2016 certified facilities in the US, and has over 30 years of experience in the antibody field.

SDIX is a wholly owned subsidiary of OriGene technologies specializing in high quality antibody development and manufacturing. The OriGene/SDIX antibody collection includes over 10,000 antibodies with options for large scale production in support of diagnostic reagent manufacturing such as Strep A, cTnI, CRP, Apo A1, ApoB, Immunoglobulins, HPT, Alb, Micro-albumin, and Calibrators. For IHC applications, UltraMAB antibodies are the only class of antibodies validated for mono-specificity. Services include: Proprietary antibody development against membrane targets, large-scale monoclonal antibody (ascites and in vitro) production, polyclonal antibody development, recombinant antibody optimization and long-term supply of goat, sheep, rabbit, mice, rat, guinea pig, and chicken antisera and purified antibodies.

Offering highly sensitive yet cost effective primary antibody and detection solutions to clinical anatomical pathologists

More than 200 different detection kits available including 1 step polymer, 2 step polymer and Biotin-Streptavidin, HRP or AP systems

With product quality and technical support that you can count upon

AOAC, AFNOR, NPIP, FDA approvals for the products
For quality systems please use this link http://www.sdix.com/About-SDIX/Quality-Systems.aspx

ImmunoHistoChemistry

UltraMAB™, Ultra Specific Antibodies for Anatomic Pathology, specificity: tested with High Density Protein Microarray
Current targets of UltraMAb’s include HER2, ALK, Ki67, ERCC1, Beta-Catenin, IDH1 and other important diagnostic targets
Extensive range of high sensitivity polymer detection kits